BR100 Increased By (0.82%)
BR30 Increased By (0.64%)
KSE100 Increased By (0.65%)
KSE30 Increased By (0.66%)
AGHA 7.80 Increased By ▲ 0.05 (0.65%)
BECO 5.20 Increased By ▲ 0.01 (0.19%)
BML 57.93 Decreased By ▼ -0.73 (-1.24%)
BOP 34.25 Increased By ▲ 0.56 (1.66%)
CNERGY 10.91 Increased By ▲ 0.30 (2.83%)
CSIL 5.43 Increased By ▲ 0.13 (2.45%)
FCCL 54.63 Increased By ▲ 0.89 (1.66%)
FFL 16.73 Increased By ▲ 0.27 (1.64%)
FNEL 1.24 Increased By ▲ 0.02 (1.64%)
KEL 7.39 Increased By ▲ 0.11 (1.51%)
KOSM 5.77 Increased By ▲ 0.13 (2.3%)
LOTCHEM 29.76 Increased By ▲ 0.11 (0.37%)
MLCF 95.68 Decreased By ▼ -0.68 (-0.71%)
NBP 204.75 Increased By ▲ 1.22 (0.6%)
NCPL 57.70 Increased By ▲ 0.85 (1.5%)
NPL 69.40 Increased By ▲ 2.09 (3.11%)
OGDC 318.45 Increased By ▲ 0.23 (0.07%)
PACE 10.81 Increased By ▲ 0.18 (1.69%)
PAEL 43.01 Increased By ▲ 1.24 (2.97%)
PIBTL 16.86 Increased By ▲ 0.05 (0.3%)
PPL 221.20 Increased By ▲ 1.03 (0.47%)
PRL 51.85 Increased By ▲ 2.80 (5.71%)
PTC 71.00 Increased By ▲ 0.99 (1.41%)
SSGC 29.25 Increased By ▲ 0.11 (0.38%)
TBL 9.88 Increased By ▲ 0.11 (1.13%)
TELE 8.92 Increased By ▲ 0.10 (1.13%)
TPL 17.73 Increased By ▲ 0.56 (3.26%)
TPLP 12.95 Increased By ▲ 0.44 (3.52%)
TREET 22.81 Increased By ▲ 0.22 (0.97%)
TRG 60.10 Decreased By ▼ -0.12 (-0.2%)
اردو
Android App
Print Edition Dollar to PKR
Intl Oil Prices Iran-US war Petrol Prices Gold Rates Podcasts PSX Notices
Topic

Oxford vaccine

Britain recommends not using Oxford/AstraZeneca vaccine for under-30s

Britain recommends not using Oxford/AstraZeneca vaccine for under-30s

Published 07 Apr, 2021 08:09pm
  • "We are not advising a stop to any vaccination for any individual in any age group. We are advising a preference for one vaccine over another vaccine for a particular age group, really out of the utmost caution, rather than because we have any serious safety concerns," he said at a briefing. It came after Britain's MHRA medicine regulator identified a possible side-effect from the COVID-19 vaccine developed by Oxford University and AstraZeneca involving rare brain blood clotting.
AstraZeneca/Oxford vaccine more effective with longer dose gap: study

AstraZeneca/Oxford vaccine more effective with longer dose gap: study

Published 19 Feb, 2021 09:17pm
  • The study confirmed the Anglo-Swedish drugmaker's findings from earlier this month that showed the vaccine had 76% efficacy against symptomatic coronavirus infection for three months after the first dose.
  • Efficacy was found to be at 81% with the longer interval of 12 weeks between the first and second dose, compared with 55% efficacy up to the six-week gap.
South Africa offers AstraZeneca jabs to AU

South Africa offers AstraZeneca jabs to AU

Published 17 Feb, 2021 11:06am
  • "The first batch of Johnson & Johnson Covid-19 vaccines have arrived at OR Tambo International Airport," Mkhize tweeted as the precious cargo landed in the financial capital Johannesburg.
Different age rules for Oxford/AstraZeneca COVID-19 vaccine in EU

Different age rules for Oxford/AstraZeneca COVID-19 vaccine in EU

Published 08 Feb, 2021 08:32pm
  • Some EU countries, though, have limited its use to people under 65 because of a lack of data for older people in clinical trials for the shot.
  • Countries that have recommended the vaccine's use for people between 18 and 64 years old:
Oxford says COVID-19 vaccine with AstraZeneca works against UK variant

Oxford says COVID-19 vaccine with AstraZeneca works against UK variant

Published 05 Feb, 2021 07:38pm
  • Britain had said that it believed the vaccines were effective against variants that are circulating in the UK.
  • Data from our trials of the ChAdOx1 vaccine in the United Kingdom indicate that the vaccine not only protects against the original pandemic virus.
Loading...